ADMISSION OF NEW ORDINARY SHARESSource: RNS
("Avation" or "the Company")
ADMISSION OF NEW ORDINARY SHARES,
TOTAL VOTING RIGHTS AND DIRECTOR'S DEALING
Further to the Company's announcement on 23 September 2019 in relation to the allotment of 270,003 new ordinary shares in the capital of the Company (the "New Shares"), the Company announces that the listing of the New Shares in the standard segment of the Official List of the UK Listing Authority and the admission of the New Shares to trading on the London Stock Exchange's main market for listed securities ("Admission") became effective and that dealings commenced at 8.00 a.m. today.
The New Shares rank pari passu in all respects with the existing ordinary shares of the Company with ISIN GB00B196F554.
Following Admission, there will be a total of 64,879,942 ordinary shares in issue. The Company currently holds 850,500 ordinary shares in treasury. Accordingly, following Admission there are 64,029,442 total voting rights for the purpose of calculating shareholders' percentage voting rights.
Roderick Mahoney, a director, increased his holding in ordinary shares to 756,667 as part of the allotment referred to above. This represents approximate 1.17 of the enlarged issued share capital and was done by way of the exercise of warrants for 56,667 ordinary shares at an exercise price of 215 pence per share. This was part of the staff warrant exercise announced on 23 September 2019.
More information on Avation can be seen at: www.avation.net
Jeff Chatfield, Executive Chairman
T: +65 6252 2077
Notes to Editors:
Avation PLC is an aircraft leasing company, headquartered in Singapore, owning and managing a fleet of commercial passenger aircraft which it leases to airlines around the world.
More information on Avation can be seen at: www.avation.net.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.